首页 | 本学科首页   官方微博 | 高级检索  
检索        

切缘阳性非小细胞肺癌术后辅助治疗现状与争议
引用本文:袁梦,门玉,康静静,孙鑫,赵茂媛,杨旭,包永兴,惠周光.切缘阳性非小细胞肺癌术后辅助治疗现状与争议[J].中华放射肿瘤学杂志,2020,29(10):904-908.
作者姓名:袁梦  门玉  康静静  孙鑫  赵茂媛  杨旭  包永兴  惠周光
作者单位:国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院放疗科 100021; 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院特需医疗部 100021
摘    要:阳性手术切缘显著降低可手术非小细胞肺癌患者的生存,然而目前切缘阳性非小细胞肺癌患者的术后辅助治疗模式尚缺乏高级别证据支持。本文综述切缘阳性非小细胞肺癌患者辅助治疗的现状及值得商榷的问题。

关 键 词:  非小细胞肺/切缘阳性    非小细胞肺/术后辅助疗法  现状与争议  
收稿时间:2019-04-09

Consensus and disputes on the adjuvant therapy for non-small cell lung cancer with positive surgical margins
Yuan Meng,Men Yu,Kang Jingjing,Sun Xin,Zhao Maoyuan,Yang Xu,Bao Yongxing,Hui Zhouguang.Consensus and disputes on the adjuvant therapy for non-small cell lung cancer with positive surgical margins[J].Chinese Journal of Radiation Oncology,2020,29(10):904-908.
Authors:Yuan Meng  Men Yu  Kang Jingjing  Sun Xin  Zhao Maoyuan  Yang Xu  Bao Yongxing  Hui Zhouguang
Institution:Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Abstract:For non-small cell lung cancer (NSCLC) patients with positive surgical margins, the survival rates can be dramatically decreased. However, high-level evidence is lacking in the standard adjuvant treatment for NSCLC patients with positive surgical margins. In this article, consensus and disputes on the adjuvant therapy for NSCLC patients with positive surgical margins were reviewed.
Keywords:Carcinoma  non-small cell lung/positive surgical margin  Carcinoma  non-small cell lung/postoperative adjuvant therapy  Consensus and dispute  
点击此处可从《中华放射肿瘤学杂志》浏览原始摘要信息
点击此处可从《中华放射肿瘤学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号